My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 181

    1.

    Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group.

    Morlet N, Minassian D, Butcher J.

    Br J Ophthalmol. 1999 Sep;83(9):1027-31.PMID: 10460769 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.

    [No authors listed]

    Ophthalmology. 1997 Nov;104(11):1902-9.PMID: 9373124 [PubMed - indexed for MEDLINE]Related articles

    3.

    Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.

    O'Brien TP, Maguire MG, Fink NE, Alfonso E, McDonnell P.

    Arch Ophthalmol. 1995 Oct;113(10):1257-65.PMID: 7575256 [PubMed - indexed for MEDLINE]Related articles

    4.

    Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis.

    Prajna NV, George C, Selvaraj S, Lu KL, McDonnell PJ, Srinivasan M.

    Cornea. 2001 Mar;20(2):175-8.PMID: 11248824 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis.

    Khokhar S, Sindhu N, Mirdha BR.

    Infection. 2000 May-Jun;28(3):149-52.PMID: 10879638 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.

    Panda A, Ahuja R, Sastry SS.

    Eye (Lond). 1999 Dec;13 ( Pt 6):744-7.PMID: 10707137 [PubMed - indexed for MEDLINE]Related articles

    7.

    Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.

    Constantinou M, Daniell M, Snibson GR, Vu HT, Taylor HR.

    Ophthalmology. 2007 Sep;114(9):1622-9.PMID: 17822972 [PubMed - indexed for MEDLINE]Related articles

    8.

    Risk factors and causative organisms in microbial keratitis.

    Green M, Apel A, Stapleton F.

    Cornea. 2008 Jan;27(1):22-7.PMID: 18245962 [PubMed - indexed for MEDLINE]Related articles

    9.

    Microbial keratitis at extremes of age.

    Parmar P, Salman A, Kalavathy CM, Kaliamurthy J, Thomas PA, Jesudasan CA.

    Cornea. 2006 Feb;25(2):153-8.PMID: 16371773 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.

    Hyndiuk RA, Eiferman RA, Caldwell DR, Rosenwasser GO, Santos CI, Katz HR, Badrinath SS, Reddy MK, Adenis JP, Klauss V.

    Ophthalmology. 1996 Nov;103(11):1854-62; discussion 1862-3.PMID: 8942881 [PubMed - indexed for MEDLINE]Related articles

    11.

    Risk factors for treatment outcome in fungal keratitis.

    Lalitha P, Prajna NV, Kabra A, Mahadevan K, Srinivasan M.

    Ophthalmology. 2006 Apr;113(4):526-30.PMID: 16581414 [PubMed - indexed for MEDLINE]Related articles

    12.

    Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in north Texas.

    Pachigolla G, Blomquist P, Cavanagh HD.

    Eye Contact Lens. 2007 Jan;33(1):45-9.PMID: 17224678 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis]

    Zhang M, Hu Y, Chen F.

    Yan Ke Xue Bao. 2000 Jun;16(2):146-8. Chinese. PMID: 12579927 [PubMed - indexed for MEDLINE]Related articles

    14.

    Risk factors in microbial keratitis leading to penetrating keratoplasty.

    Miedziak AI, Miller MR, Rapuano CJ, Laibson PR, Cohen EJ.

    Ophthalmology. 1999 Jun;106(6):1166-70; discussion 1171.PMID: 10366087 [PubMed - indexed for MEDLINE]Related articles

    15.

    Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers.

    Bennett HG, Hay J, Kirkness CM, Seal DV, Devonshire P.

    Br J Ophthalmol. 1998 Feb;82(2):137-45.PMID: 9613378 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin.

    Ly CN, Pham JN, Badenoch PR, Bell SM, Hawkins G, Rafferty DL, McClellan KA.

    Clin Experiment Ophthalmol. 2006 Jan-Feb;34(1):44-50.PMID: 16451258 [PubMed - indexed for MEDLINE]Related articles

    17.

    Treatment of experimental bacterial keratitis with topical trovafloxacin.

    Barequet IS, Denton P, Osterhout GJ, Tuli S, O'Brien TP.

    Arch Ophthalmol. 2004 Jan;122(1):65-9.PMID: 14718297 [PubMed - indexed for MEDLINE]Related articles

    18.

    Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.

    Hu FR, Luh KT.

    Ophthalmology. 1998 Feb;105(2):269-72.PMID: 9479286 [PubMed - indexed for MEDLINE]Related articles

    19.

    Trends in contact lens-associated microbial keratitis in Southern India.

    Sharma S, Gopalakrishnan S, Aasuri MK, Garg P, Rao GN.

    Ophthalmology. 2003 Jan;110(1):138-43.PMID: 12511359 [PubMed - indexed for MEDLINE]Related articles

    20.

    Corneal ciprofloxacin precipitation during bacterial keratitis.

    Wilhelmus KR, Abshire RL.

    Am J Ophthalmol. 2003 Dec;136(6):1032-7.PMID: 14644213 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity